arrow
M

Michael C. Churnetski

Ctr Res and Technol Hellas
H指数:14
被引数:796

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

PD-1 Expression Identifies Proliferating Chronic Lymphocytic Leukemia Cells and Informs Response and Resistance to BTK Inhibitor Therapy

PD-1表达可识别增殖性慢性淋巴细胞白血病细胞,并提供关于BTK抑制剂治疗的应答和耐药信息。

BLOOD
IF23.1
2024-11-050
PRE
Outcomes of patients with blastoid and pleomorphic variant mantle cell lymphoma
2023-12-135
OAAI
Postibrutinib relapse outcomes for patients with marginal zone lymphoma
2023-01-101
OAAI
Predictive factors and outcomes for ibrutinib in relapsed/refractory marginal zone lymphoma: a multicenter cohort study
2022-07-164
OAAI
Early relapse identifies MCL patients with inferior survival after intensive or less intensive frontline therapy
2021-12-0728
OAAI
Multicenter analysis of geriatric fitness and real-world outcomes in older patients with classical Hodgkin lymphoma
2021-09-2415
OA
Multi-center analysis of practice patterns and outcomes of younger and older patients with mantle cell lymphoma in the rituximab era
2021-08-1015
OAAI
HIV-associated Burkitt lymphoma: outcomes from a US-UK collaborative analysis
2021-07-2027
OA
Outcomes of Burkitt lymphoma with central nervous system involvement: evidence from a large multicenter cohort study
2021-02-0420
OAAI
Outcomes of patients with limited-stage aggressive large B-cell lymphoma with high-risk cytogenetics

具有高危细胞遗传学的局限性侵袭性大b细胞淋巴瘤患者的预后

2020-01-1633
OA
Outcomes in patients with aggressive B-cell non-Hodgkin lymphoma after intensive frontline treatment failure

强化一线治疗失败后侵袭性b细胞非霍奇金淋巴瘤患者的预后

CANCER
IF5.1
2019-09-3027
OAAI